![PharmaTalkRadio artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/a8/76/ea/a876eaec-f9ae-a355-f856-8dd8b8dc62f1/mza_8144839391309294325.jpg/100x100bb.jpg)
5th Annual Immuno-Oncology 360˚: 12 minutes of What to Expect
PharmaTalkRadio
English - November 19, 2018 06:30 - 13 minutes - 11.8 MB - ★★★★ - 16 ratingsScience pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
IO360° brings together science, clinical and business under one roof to accelerate treatments to fight a wider range of cancers. This brief podcast gives you an overview on what you can expect at IO360°.
The three-day summit features 10 plenary sessions with over 80 speakers and includes ten plus hours of networking. There will be over 450 attendees.
Key benefits:
Access to KOLs driving the sciencePartnership opportunities with all stakeholders in Immuno-OncologyPresentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology
IO360° is chaired by Dr Andrew Baum, Citi along with Dr Axel Hoos, GlaxoSmithKline and Dr James Gulley, National Cancer Institute.
Learn more information about IO360° at www.io360summit.com
Take 10% off the regitration fee with code RADIO